Intas Pharmaceuticals
Onkar Kirdak is a Research Associate in Formulation and Development at Intas Pharmaceuticals since September 2024, previously serving as a Research Scientist at Murli Krishna Pharma Pvt. Ltd. from November 2021 to September 2024, where responsibilities included formulation optimization and development of oral solid dosage forms. Onkar holds a Master of Pharmacy degree from Sinhgad Institute of Pharmacy in Narhe Pune, completed in July 2021, and a Bachelor of Pharmacy degree from D.S.T.S. College of Pharmacy in Solapur, obtained in June 2019.
This person is not in the org chart
This person is not in any teams
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.